Breaking News

Bora Pharmaceuticals Installs New Filling Line at Its Mississauga Facility

Expands its production capabilities and enables larger volumes at higher speeds with greater flexibility, particularly for dermatologic products.

Bora Pharmaceuticals Co. Ltd., a pharmaceutical manufacturer, has installed a filling line from Norden Machinery at its Mississauga, Ontario manufacturing facility, expanding its production capabilities and enabling larger volumes at higher speeds with greater flexibility, particularly for dermatologic products.

The new Norden filler is the third tube-filling line at the site and is capable of producing approximately 7 million to 15 million units per year, increasing the site’s total production capability to more than 50 million units annually. It can handle metal, plastic, and ABL tubes and includes laser printing capabilities. The upgraded line is fully kitted out to pack the tubes into a wide range of cartons, then bundle, and automatically pack them into shipping cases. The line is qualified for PODA and Track and Trace serialization, allowing more than 20+ of Bora’s markets to be packaged on this line.

“This filling line complements our deep expertise in semi-solid formulations and strengthens our ability to help customers scale up efficiently,” shared John Lawrie, VP of Operations for Bora Pharmaceuticals. “The upgrade significantly expands our capacity, allowing us to address growing demand for high volume production not just from our current partners, but from the marketplace as a whole.”

The system can accommodate a wide range of fill volumes, from 2g to 150g, and further supports scalability in the wide range of manufacturing vessels, specifically for semi solid manufacture that range in size from 2.5Kg to 3600Kg. This flexibility enables Bora to accommodate a variety of customer needs, all while maintaining cost efficiency and quality. The facility is also routinely inspected by multiple global regulatory agencies, with products currently exported to a growing number of regions, including North, Central, and South America; Europe; Asia; Russia; the Middle East; and Australia.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters